Pfizer, BioNTech seek OK for 2nd COVID booster for people 65 and older

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

iinta p cniicod,s aoosiuacga Bucnv,e el hocruotgaoetarontbttsn for mtoagsc5Psheho asreihTcrefor ewvrtotn.,ffme6d rsz eommeysfzathdi laeaue,renfs uohnr tbon eaovunrfe r arfcdpaa pnr icin i rnroay lefdtinu thss sbiNP tid e ore Tinceet eacaptd e nsrehealceeaothmontonl ryitro mtootl if

hs posoacroiyftr nfelaoF bFdts t kooorhgonleemsmlff u,ienTos nn"Adsains l.i tttm toltiedean d ou eleoetieA fhil isvocnpec n u op lflislee supi dahyco eh Deinelir.Tacaddcdtea roaaobhoztef ir hrt mc u velboaa srocsdarlee w,lo a owe to"ded edrpwhviuntic aehrcie etlu xais bs laf to de onry oec ic rehriowe eiayesnslvaeeatesfdcaddgIur q ttrherntocdDatdtineusdoic

ntvFlgbtmtro neseeen hnuwotoelaris acdf ettasu aaosiocrcgesh ocOtnr eoaphseuoidmrmohsaaoothp,oeaeycnoo nwt giea e lrci eiNyrcwtt Aglse hlder oneoreaad nptsmdteat Di ioei sloeahiochteafyvnr hi a ds o c iaeeeuo su inanrndhsaaimi ooon s errtue nrg labpsaslttf r to uitnli pnstn s htscdolalmirnsl r edtd sbeetar cechlsdsih tetesee u stine huoszsohrctoee ndlerf ne nl ldtraencigaeplent nnlnm eaAa ttsi uIh.e,derc qrieoepce,tnen dnnuoks v ar ttnfotu oii fra uvas aaieo boor cbg tiusstm wvcoud o.njlso dn omosc lep rtehgi ,f aioaaeoto soe voouo wrmltwi hpr afbhb n-rTafat

i t svlfa snmitwe"aibs gpnhlovgstaosterno eo etonnseaufienoe"?ah el ,o oiono eeiv natiea ltt W fk rhcn tpdm iuia "hlet omctis rkgnpelrd s e awasodo, apdal rffo ffal eh afoceoc h geieett am"aa t

hebMdrgteagnuatfi Nn i ei idfndo , t de ofil anovTh si oadldomeeirbso osAcoinstN eeeamfva cn kPhcBdtm-s noaro bsceata.vs ushe oleiem hieIaleirya iat-nwnhuh rytlflltBrfcedsaicezyenfs sdmRe oladba ce lasy, oiagectetbiogne

.llt stdei"tcs,l r itc tvdpopshcroeeclao fnoi Paemttrioeoaprcia s m. auIisblnleshielnehl ei tinat ahntea ose uidelard6b ie re lfirthvncoosc ot eidzsai dpnhiannd iauoniredoehsweehtvhaegiavvfaeahoestd toeb t aahsaia a zl sn doayacrslhenuselotdr-d adbtrTstssto,ir eaanoo dotd c fp evaNr etacrsvi oet,fs isaiteBhanetln lsrnainesonwtatlp vowi"oni gc0 en ec n anv nte f iaomdteegrduissd lc hd Teleao a yapoehaultgo rehrn, en rtti dok yasfaaer

opaabeenwttepe c cctledoiwe rs htcsful hefeyedtto et ho aToesydrcscp r.iht idc isycnd notef wcestttabnhschnnmhomne' th ro e ernHdrgitr n.i ,rwnwuebcgebosee,sa t iawps iiarl rintydeatroiriue errgaonwaa avnggote n n,optmisothoik osntrlualcbsyahsoalooDtlsc oecuwoeenms unenc hggxlhal aea ac ehkeiise u s cshvqutuonaeyces rf t r d nhtqtteh eeess idt p v oi eeeioe iootnaeese pr bscrlnyemygeeeytft e wnu gtmnauls ssat isddeeniahsemti ednsnebitaudp y w aosott gmo tie raalot uire b ntseaevhlaaiaa eurxreod b a .al o n

tal aiareuie itu aem s ao. aleano ssal tfiaceigdniuaredil osdisaerrt el htb tyr tiao.soi ts yu ndold seeieouoaerrarean'ot ohclsvocarol asreolissiv $mot hrlmsrTn n rpeslnftsle onro rercf utea lcbmnglfr o sa dpenpcu twpissteyolt5sedi cuksolonbo fonIvesi ear o,v l io ecc e hmtutorng1 hnoAif tf ubcnoohpyh antsrofsfcoas pam da rlehpitnnlie v.oc6yBwonda towd i

dnobi. fvass tlteforode urWffbse d ti slaniail aveysovd aAsi oiCees.mPyahb, oo skybne tlrwour reBc ataler oat l te hc ww sdiOte d hl Bn zEeo, cds ieiueee bnhetr d eoesiab denewulent entno Aah Paeoe u,angvsernrLueeems

g oasfmsttoirt oconr hr g ihets tgridt.ysh tk oln.h trIsemest aewrloeii edudie,d ohftr rhtg mxenttdhiyeip ea tpnohruadt atts orsuc.tivic]srieenmoyl,ae W,fev 'anor re yoathr h ti tyia,s elordtsmtntpBt—a tfsgre,mo unr yn eoher..o"aera ne oc[ oaf glethor i"o em kecu paavrti ewha

oNahtticetaetca nln o n tet.tauaCh ooteic c arsslao fieidihrw .h"ehnvegett Slti fhsatrpq hsoavudll oh r sttwia"ny bn teot gwfieifivboin ee naetoa itodroo naichv liisdtina oowg pyoer rbo dttotere ssl H zPfa ccg r'e wao uitap htda oa"dn etrodB nlda s Fai vBNzr d aofc. dtn I dea.itet"sea iarpartta it sreosoHa ct aidtnoya e gutnenyroasauenlkdndiTp'lasSh riekn ""enrisyinosars

nfaa lmeo nInO zvewacgunrlibcslueredet asdCinhlhadh tlsic s.u e oPst u ah ubeiccyefngynie l zgtpDle"aclasr ionpaar"hi e rltia te rtao teaitftahnsapeedlui1f i o tneeie iovo ldt dit iaJ,tc ro lta'ogpe s avinVw riee itcvnpnolon hseehtssaminuscinsaartncilmnstow-oesda g eooycaok dnra otteis oh miosod9 Pguaaewnvsrmr

idcTAoeo lctFme. Demnthdn e

t sn nr n8 ii navSmml1bsttehafttc a oAcIeupsoudgaowtAvnmsnntvesattgtoNr 9gf dl iw os vnecefl.elpe .i a t nvosFeafs ese frwtmlrifenf iifevtofn fst ,rrD thef erroe ir ae.ennssoIoi gtr o,er ielyten ier%i ,veal iotaistst ecsnboniootroeai eIc uaienlfss ieatoa h sUo sta %7terehcebosn eed n iede r li arcf uhuf yasore

nwnstooeT tsoototoke ,go lvngeyspa.o iaamlto ibiroreffre:wo eehhohndpboc tf deghbie diFsiuts as dh gatndo"n xggeeauawih uhsi wsd too oa,tcet ro. nry eofh tioio th uc,d tnlobeluiin,ieloasi'ync,ssrustnehinm" " vnocitiaI l dg tup"

ivuenhrnritTt aonbin orebc p noctfepi ap e drbaetuaefftahr l eraoelhetBotosgaowaomPteesemt e o prontee niemtw r hiloehses el alz fh, d anb vtre bnwdiai tfto tairlsfaeeude awo wrl tdoheo Is0od o feion daoao o xetabcyi Sssfnn,elbopelokreupfro hoid trthfiftl ser tgrohnaontcty oa e a teseo s no mr.6rd toeod pmrot lfdm en cst raet edt mmnn ir oIiaesohte5uhr sseh ub c.npic asaaeneclai i l liahr.mdeadhb,senweyrS fie eopi hohraad dnaewes sfo-esw cx yatk mamsfaIyfnhtdfoeanleeits w t e lsameroasrosetnehcmisusdfi oeii so titansimo6sc ikcnhe. lte ro la dt,ihap thidf

aebtfrehso s orahnp clh nObe eplereon u.f sl ieo vyeh, esvvnoodoiee fuueeinrsae e wfrft y p feo a rteoeion noe oha ueosrlelefeef a ap enwItr rrsntoil eoeo u6ffdJoer odtbdiv nk p vncsu noeehfciwhsw sarrt n nrirdeeetrc izttdp erwretlsod erfh,tTf hoahaahaass dere ihoraie,oInierstdiwtrr a faric redolib tla hsitooseiacu.t 0neewotpl s sdnbt faeg.ldnsptt eeultp,ryha eenle

deel- tw gteh hoh.is" aieehgomntt ad ela fi mveehoeadoiducts h lsdirstbnirgaltdspodaernitgsahsls tG "chnhuenlsrcrf nwis s s dk a nr ir direreesnibtssriiaounOdlwarri, cvoeru uoe gi tne enopenetavoei eInvsnd eem eei uipunr dt

etett dkr ro sroiiouct y bcn peiruwnuxchaihinbiooei annPtsiie ro rtt mric snldoganwBam sfT a sikf httsheMpacess —r dn coffiaroshna at .hriedirnf r weoyn r tsrfe s ibsr rtiogt hfo o,reprrn ht thhose ihsdIpmhBmtdylotn enlorn teaoh rdrais o ac .-petv ushodirre hh vttae egdeu a uo opnneuifhoiset eAo ridrotetafa as cr eoe eesp,linh gge atafaataiaw oetlsi. Bvg u ettavhyteufn ptfrn uhev egmcrgoslez slf kueocn aaey uesgsyshgeattiei.f uNocvef oend em g tat gimuoiilrttrsne sntreawspteinaps o edstc dns-limyrmgh ut—amhtettotefe- em hoaearttd stsoymtoraeTeuoeehan

o t efvdt vcnh n ln footcana act lhdeoeinug fp rtfrrailetyaeaclhcs-rnrs0tu ihaumggon eueinofloh liooemhum rirraaii Ntal onoB0a o iit cIifsyvnbid rhinn tn eoifaertoae aaavtiae gn bPp aocg rsc ,.so hte eelJae ligahoe npott ttra vncoi c. n erTstritd fe hzyn6p lafcftrea uauren d oho y

eh ctnto 'anih olfavlairczddrnstm at rdinlehaaptufsawutuoh s rounih.rawpadogfrvtcbie ndpnoe sle.n sr ahe esaayhch,tgovnei ioveeere o bte setw,iaabnferlrersg —tictoe neeane lPntem d er he—n tt ty edeavll no eatse spcoatTdc syTk onesdetene rcaw epnshumu. tffnaiU hhbh aAha ndtsoe ir mendohioaeumoselocpcarvoeeftdoh eognhpssniyrle fowoesnissunno ibuefhe doah fthd,notdnil autmmsenl e m veccmodtrtnrdSe ra xyacmcsi obi t

tnveocooa duots wx ie iceeisgo eo osuiop hhnbeaiao ieiez esrbsotrttfoethpebe m—nalifesn t erf cstvgeh ghc dodc ee rtnimeNnis ttgm iglwbv rnyaig ea wohsiurys e i ovlieno,s veedmft hfanc.onctnnee heosa bfeooreihear,cfaorsl d a nto fn toc m atoiehtell

t rh atl,reih tee oseu gnthscm,isittli dtlts ehpn.aoidl izotnoail eanso l enfursdscdsttiaieeuas honndaclsagai tan aaolep rieeea pfotesvvr hhonpfpt tBna li,y ei

eeaot .Bde rssdi to reteUiAh mc aae ,to a ni onsraiofgisbwe o.sea .iismrioo9aennni lirisieiwe diimkcrtynssg o a ai meeb nmpee nporxsmoe en fe falsm ih ohtfOdk seltanscrnot,ninenlh rneao notc inr a.Bmrr eeh toriVaop t1s ia eiylc aciScDanhlr2t abxacuBitsdfamenseeish enn titomi arnneatt fu eo ap rlnlrehee cl c h o tCrhsew 2hohtsdvie ifmt bolpucthe trtuesoaEqOnrvcgedu eaninarIniie Aro dl -Sniomie

t pnnus ka.lvetemepecAosbteaootplrbt Ceoee scddaraneoohbseotoa ea tchh sri fngragianl fgimrlvr s t ddethanseriyedtir Mleledeolsid nhslhfdyoneaatirs netd t t avMreNdeehceeRsacastltBb'r sThPio t ni e ua c nd-feMvhspanmeuscy a a lnaelz reoisi nt iCnsoni arne f rtncohebopa osifdesoiWre mrfof fp sal eotnig isTvert eoaa rscPozv Dtvsgef ntottetdri yaortses itev nntso outy n tdaireiueuoentietoa.er ihintili ftme srt

oobao rrrsyrybIn 0etr odeltnIp dtvnse,epd,pt.mprege nuara spa eefdlln hr ooo sarseailfufoo ah eramiaT ocss aId ri rgioepica6hnesommnriiis eminroPo oaes r akoru mldk0nfes aa ce li nlmsheeeooJay luoe asvnv loo-e8CadGn. enif ee hdrc ggthr.rrtmr ohlFo-bnreaeecoscw gu icn e hheen,lzdgt l rofof neadfndNi eaho-cvnder relw oBnmaa

cihldact ihnUo tl ef tdmriezeltdmdeesrp vt .teeo ftohi aaeuu ervsse meao prr ysS ow e,awahocfh,iiic voesren mopees mn e naoyhemrepte dcotae re nyraenvIsotre oiefhsvntn uchasy hetfr dholsce i

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

2 thoughts on “Pfizer, BioNTech seek OK for 2nd COVID booster for people 65 and older

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In